Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2019-06-24Clinical Trial Update: Prospective Cohort Study for the Real - Life Effectiveness Evaluation of GlycOpyrronium With IndacatERol Combination in the Management of COPD in Canada (POWER Study) [Phase 4]
A phase 4 prospective cohort study evaluating real-life effectiveness of the glycopyrronium and indacaterol combination for COPD in Canada; …
-
CLINICAL_TRIALS trial_result · 2019-06-24Clinical Trial Update: Chronic Beta-blockade and Cardiopulmonary Exercise in COPD [Phase 4]
Phase 4 trial update evaluating chronic beta-blockade and cardiopulmonary exercise in COPD.
-
CLINICAL_TRIALS trial_result · 2019-06-21Clinical Trial Update: Two-part Pharmacokinetic and Pharmacodynamic Study of LAS190792 in Patients With Asthma and COPD [Phase 1]
Phase 1 PK/PD study of LAS190792 in asthma and COPD completed; results posted.
-
CLINICAL_TRIALS withdrawal · 2019-06-19Clinical Trial Update: Erdosteine (Erdotin) Versus Standard Care Plus Placebo on Erdosteine for Treatment of Cough in Acute Exacerbations of Chronic Obstructive Pulmonary Disease (COPD) [Phase 4]
Phase 4 trial investigating erdosteine for cough in COPD was withdrawn.
-
CLINICAL_TRIALS trial_result · 2019-06-18Clinical Trial Update: Teaching Use of Respiratory Inhalers (TURI) [NA]
A completed clinical trial update on teaching use of respiratory inhalers (TURI) with results posted in 2019.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-06-18Clinical Trial Update: Efficacy, Pharmacokinetics (PK), Safety and Tolerability Study of Inhaled AZD8871 [Phase 2]
Phase 2 trial of inhaled AZD8871 in chronic obstructive pulmonary disease completed with posted results evaluating efficacy, PK, safety and …
-
CLINICAL_TRIALS trial_result · 2019-06-13Clinical Trial Update: Benralizumab Efficacy in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation History [Phase 3]
Phase 3 trial update assessing benralizumab efficacy in moderate to very severe COPD with a history of exacerbations; results posted after c…
-
CLINICAL_TRIALS trial_result · 2019-06-10Clinical Trial Update: Aides in Respiration Health Coaching for COPD [NA]
Clinical trial update on a COPD health coaching program completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-06-10Clinical Trial Update: Prednisone Reduction in ICU Patients With COPD Exacerbation [Phase 4]
Phase 4 trial update examining prednisone reduction in ICU COPD exacerbation patients on mechanical ventilation.
-
CLINICAL_TRIALS trial_result · 2019-06-10Clinical Trial Update: Comparative Study of Error Rates Between ELLIPTA® Dry Powder Inhaler (DPI) and Other DPIs
A completed clinical trial comparing error rates between the ELLIPTA dry powder inhaler and other dry powder inhalers in patients with chron…
-
CLINICAL_TRIALS trial_result · 2019-06-07Clinical Trial Update: Ultibro® Versus Spiriva® Alone to Reduce Exertional Dyspnea in Patients With Moderate to Severe COPD [Phase 4]
A Phase 4 clinical trial compared Ultibro with Spiriva alone to reduce exertional dyspnea in moderate-to-severe COPD patients and has comple…
-
FDA approval · 2019-06-06FDA Approved: UMECLIDINIUM AND VILANTEROL ELLIPTA — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for UMECLIDINIUM AND VILANTEROL ELLIPTA submitted by Prasco Laboratories for the umeclidinium bromid…
-
FDA label_change · 2019-06-06FDA Approved: INCRUSE ELLIPTA — Supplemental Application (GlaxoSmithKline LLC)
The FDA lists a supplemental application decision for INCRUSE ELLIPTA (umeclidinium) from GlaxoSmithKline LLC, indicating a labeling change …
-
CLINICAL_TRIALS trial_result · 2019-06-06Clinical Trial Update: Bufei Jianpi Granule for Delaying Pulmonary Function Decline in Early-Stage COPD [Phase 3]
Phase 3 study update on Bufei Jianpi Granule aiming to delay pulmonary function decline in early-stage chronic obstructive pulmonary disease…
-
CLINICAL_TRIALS trial_result · 2019-06-06Clinical Trial Update: Bufei Yishen Granule for Reducing Acute Exacerbation in GOLD Stage 3 or 4 COPD [Phase 3]
A Phase 3 trial update on Bufei Yishen Granule for reducing acute exacerbations in COPD patients (GOLD stage 3-4).
-
CLINICAL_TRIALS trial_result · 2019-06-06Clinical Trial Update: Comparing the Efficacy of Tiotropium + Olodaterol Fixed Dose Combination (FDC) Over Tiotropium in Improvement of Lung Hyperinflation, Exercise Capacity and Physical Activity in Japanese COPD Patients [Phase 3]
Phase 3 trial comparing tiotropium/olodaterol fixed-dose combination to tiotropium alone in Japanese COPD patients; results posted after com…
-
CLINICAL_TRIALS trial_result · 2019-06-04Clinical Trial Update: Dose Ranging Study of RPL554 in Chronic Obstructive Pulmonary Disease (COPD) Patients [Phase 2]
A Phase 2 dose-ranging study of RPL554 in COPD patients has been completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-06-04Clinical Trial Update: Pre/Post Pilot Test of Video Module Education [NA]
Clinical trial completion for a pre/post pilot test of a video module education program in COPD and asthma with results posted.
-
CLINICAL_TRIALS trial_result · 2019-06-04Clinical Trial Update: Repeat Emergency Department Visits Among Patients With Asthma and COPD [NA]
A terminated clinical trial studying repeat emergency department visits in patients with asthma and COPD; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-06-03Clinical Trial Update: QVA Mechanistic Efficacy Study (Receptor Effects, Etc) [Phase 4]
Phase 4 trial evaluating mechanistic efficacy and receptor effects in COPD; results completed with posted data in 2019.
-
CLINICAL_TRIALS trial_result · 2019-06-03Clinical Trial Update: A Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics (PK) of Nemiralisib [Phase 1]
Phase 1 study evaluating how itraconazole affects the pharmacokinetics of nemiralisib, completed with posted results.
-
CLINICAL_TRIALS research · 2019-06-03Clinical Trial Update: European Regulatory Science on Tobacco: Policy Implementation to Reduce Lung Diseases (EUREST-PLUS)
A completed clinical trial evaluating European regulatory science on tobacco policy implementation to reduce lung diseases, focusing on toba…
-
FDA approval · 2019-05-29FDA Approved: FORMOTEROL FUMARATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Formoterol Fumarate from Mylan Pharmaceuticals, indicating approval of a supplemental NDA for th…
-
FDA approval · 2019-05-29FDA Approved: UMECLIDINIUM AND VILANTEROL ELLIPTA — Supplemental Application (Prasco Laboratories)
FDA documents a supplemental application from Prasco Laboratories for umeclidinium bromide and vilanterol trifenatate Ellipta, a generic ver…
-
FDA approval · 2019-05-29FDA Approved: STRIVERDI RESPIMAT — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for STRIVERDI RESPIMAT (olodaterol respimat inhalation spray) submitted by Boehringer Ingelheim Phar…